iShares Exponential Technologies ETF (NASDAQ: XT)

iShares Exponential Technologies ETF (NASDAQ:XT), Quote.Headers.trade-ideas

Technology

Healthcare

Industrials

Utilities

Consumer Cyclical

Basic Materials

Financial Services

Communication Services

Other

Real Estate

Consumer Defensive

The fund generally will invest at least 90% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The underlying index is a subset of the Morningstar US Market Index and the Morningstar Global Markets ex-US Index family.

Nvidia  Corporation 

Broadcom Inc

Toast, Inc.

Coinbase Global, Inc.

Arista Networks Inc.

Monolithic Power Systems, Inc

Palantir Technologies Inc.

Tdk Corp

Taiwan Semiconductor Manufacturing Co. Ltd.

Guidewire Software Inc

iShares Exponential Technologies ETF

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Long Ideas

Sector ETFs

Markets

Tech

Trading Ideas

ETFs

An Exponential Idea For Blockchain Exposure

Broad U.S. Equity ETFs

Health Care

General

AAPL

GOOGL

MSFT

An ETF For The Future Of Tech

Bonds

New ETFs

Intraday Update

FSLR

TOTL

These New ETFs Hit The Ground Running

XIE US TR USH BD ETF

X S&P500 x2 SH ETF

Innovator U.S. Equity Accelerated Plus ETF - April

XANTIPPE RES LTD NEW by XANTIPPE RES LTD.

XTC Lithium Ltd

XTACY THERAPEUTICS CORP by Xtacy Therapeutics Corp.

Xtacy Therapeutics Corp

HighCom Ltd

BondBloxx ETF Trust BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF

XTEP INTL HLDGS UNSP/ADR by Xtep International Holdings Ltd.

Xtep International Holdings Ltd

OLIVE RESOURCE CAP INC by OLIVE RESOURCE CAP INC.

Olive Resource Capital Inc

TEST SEC X by Test Co

XTRA-GOLD RESOURCES BVI by Xtra-Gold Resources Corp.

Xtra-Gold Resources Corp

XTI Aerospace, Inc. Common Stock - Common Stock

XTI Aerospace Inc

XTRACKERS II TIPS US INF LIN BON ETF

Innovator ETFs Trust Innovator U.S. Equity Accelerated Plus ETF - January

Innovator U.S. Equity Accelerated Plus ETF - July

X3 Holdings Co Ltd

SPDR S&P Telecom ETF

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTL Biopharmaceuticals Ltd

ISHARES 20 YR US TR BD IX UN ETF USD

Torum

XTM Inc

XTREME MOTORSPORTS INTL by Xtreme Motorsports International, Inc.

Xtreme Motorsports International Inc

SPDR S&P Transportation ETF

Xtant Medical Holdings, Inc. Common Stock

Xtant Medical Holdings Inc

Innovator U.S. Equity Accelerated Plus ETF - October

XTEP INTL HLDGS LTD ORD by Xtep International Holdings Ltd.

Xtra Energy Corp

Global X Funds Global X S&P 500 Tail Risk ETF

XTRACT ONE TECH INC by XTRACT ONE TECHNOLOGIES INC.

Xtract One Technologies Inc

BondBloxx ETF Trust BondBloxx Bloomberg Three Year Target Duration US Treasury ETF

EXTREME BIODIESEL INC by Extreme Biodiesel, Inc.

Extreme Biodiesel Inc

X-Terra Resources Inc

COMET LITHIUM CORPORATION by COMET LITHIUM CORPORATION

Comet Lithium Corp

BondBloxx ETF Trust BondBloxx Bloomberg Two Year Target Duration US Treasury ETF

BondBloxx ETF Trust BondBloxx Bloomberg Twenty Year Target Duration US Treasury ETF

ADASTRA HOLDINGS LTD by Adastra Holdings Ltd.

Adastra Holdings Ltd

Tezos - United States Dollar

XTZDOWN - United States Dollar

XTZUP - United States Dollar

News

Telos Expands Enrollment And Renewal Options By Opening New Locations

Canaccord Genuity analyst Joseph Vafi initiates coverage on Core Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) with a Buy rating and announces Price Target of $16.

Price Target

Initiation

Analyst Ratings

Core Scientific, Inc. - Class A Common Stock

CORZ

Canaccord Genuity Initiates Coverage On Core Scientific with Buy Rating, Announces Price Target of $16

Piper Sandler analyst Korinne Wolfmeyer maintains Kenvue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>) with a Neutral and raises the price target from $20 to $21.

KVUE

Piper Sandler Maintains Neutral on Kenvue, Raises Price Target to $21

Biotech

TOVX

Theriva Biologics Reaches Target Patient Enrollment In VIRAGE Phase 2b Trial Of VCN-01 With Gemcitabine/Nab-Paclitaxel For Metastatic Pancreatic Cancer Treatment, Conducted Across 15 Sites In Spain And USA

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2024/09/20/final-trades-samsara-constellation-energy-aptiv-and-the-indy.html">Halftime Report Final Trades</a>,&#8221; Joshua Brown of Ritholtz Wealth Management said Samsara Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) <a href="https://www.benzinga.com/quote/IOT/earnings">hit an all-time high on Friday.</a>
On Sept. 5, Samsara reported quarterly earnings of 5 cents per share which beat the analyst consensus estimate of 1 cent per share. The company reported quarterly sales of $300.20 million which beat the analyst consensus estimate of $289.54 million.
Stephen Weiss of Short Hills Capital Partners picked iShares India 50 ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDY#NASDAQ">INDY</a>), saying declining interest rates are good for emerging market economies.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage her</a><a href="https://www.benzinga.com/premarket/">e</a>
Jenny Van Leeuwen Harrington of Gilman Hill Asset Management said Aptiv PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) trades at 9.5 times earnings, with 20% earnings growth over the next three years.
On Sept. 20, Wells Fargo analyst Colin Langan upgraded the rating for Aptiv from Equal-Weight to Overweight and raised the price target from $78 to $87.
Joseph M. Terranova of Virtus Investment Partners named Constellation Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) as his final trade.
On Sept. 20, Constellation Energy announced it signed a 20-year power purchase agreement with Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>). The deal entails the launch of the Crane Clean Energy Center (CCEC) and the restart of Three Mile Island Unit 1, which was <a href="https://www.benzinga.com/markets/equities/24/09/40957437/microsoft-taps-constellation-for-20-year-carbon-free-power-3-400-jobs-coming-to-pennsylvania">closed five years ago.</a>
Price Action:
<ul>
<li>Samsara gained 3.8% to close at $49.39 during Friday's session.</li>
<li>Aptiv shares fell 1% to settle at $69.84 on Friday.</li>
<li>iShares India 50 ETF gained 1.2% during Friday's session.</li>
<li>Constellation Energy shares jumped 22.3% to close at $254.98 on Friday.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40962695/jim-cramer-viking-has-many-ships-coming-in">Jim Cramer: Viking Has &#8216;Many Ships Coming In&#8217;</a></li>
</ul>
Image courtesy of Samsara

Media

APTV

INDY

Samsara, Aptiv, Constellation Energy And More On CNBC's 'Final Trades'

Matthews International Corporation (NASDAQ GSM: MATW) (the "Company") today announced a proposed private offering of senior secured second lien notes due 2027 (the "Notes"). At or prior to the closing of the offering of the Notes, the Company intends to amend its senior credit facility to, among other things, permit the Notes to be secured by a second priority lien on substantially all of our and certain of our domestic subsidiaries' assets, and the Company and certain of its domestic subsidiaries intend to enter into a second amended and restated pledge and security agreement pursuant to which the Company and such subsidiaries will grant to the secured parties under the senior credit facility a first priority lien on substantially all of the Company's and such subsidiaries' assets.
The Company intends to use the net proceeds of the offering, together with borrowings under the Company's senior credit facility, to redeem all of its outstanding 5.25% senior notes due December 1, 2025 (the "Existing 2025 Notes") on or about October 25, 2024, and to pay accrued and unpaid interest on the Existing 2025 Notes to, but not including, the date of redemption, and to satisfy and discharge the indenture governing the Existing 2025 Notes.

Offerings

MATW

Matthews International Announced A Proposed Private Offering Of Senior Secured Second Lien Notes Due 2027

Jabil Expands Silicon Photonics Capabilities At Ottawa Site To Support New Product Introductions For Hyperscalers And AI Data Centers, Set To Roll Out In Q4 2024

Morgan Stanley analyst David Arcaro maintains Public Service Enterprise (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEG#NYSE">PEG</a>) with a Overweight and raises the price target from $83 to $95.

Morgan Stanley Maintains Overweight on Public Service Enterprise, Raises Price Target to $95

Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq:&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4260606-1&amp;h=4181839075&amp;u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Finnovative-eyewear-inc-announces-exercise-of-warrants-302236683.html%23financial-modal&amp;a=LUCY">LUCY</a>), the developer of smart eyewear under the Lucyd&#xAE;, Nautica&#xAE;, Eddie Bauer&#xAE; and Reebok&#xAE; brands, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 263,160&nbsp;shares of the Company's common stock originally issued by the Company on&nbsp;May 29, 2024, each having an original exercise price of&nbsp;$9.50&nbsp;per share, at an exercise price of&nbsp;$9.875&nbsp;per share. The closing of the warrant exercise transaction is expected to occur on or about&nbsp;September 24, 2024, subject to satisfaction of customary closing conditions.
H.C. Wainwright &amp; Co. is acting as the exclusive placement agent for the offering.
The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (File No. 333-279873).
The gross proceeds to the Company from the exercise of the warrants are expected to be approximately&nbsp;$2.6 million, prior to deducting placement agent fees and offering expenses. The Company expects to use the net proceeds from the transaction for working capital and general corporate purposes.

LUCY

Innovative Eyewear Announces Exercise Of Warrants For $2.6M Gross Proceeds For The Immediate Exercise Of Certain Outstanding Warrants To Purchase An Aggregate Of 263,160 Shares Of Common Stock Originally Issued By The Company On May 29, 2024, Each Having An Original Exercise Price Of $9.50 Per Share, At An Exercise Price Of $9.875 Per Share

Cantor Fitzgerald analyst Prakhar Agrawal reiterates MoonLake (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLTX#NASDAQ">MLTX</a>) with a Overweight.

Reiteration

MLTX

Cantor Fitzgerald Reiterates Overweight on MoonLake

Alaska Airlines Expands Cargo Division Following Hawaiian Airlines Merger, Names Ian Morgan VP Of Cargo And Jason Berry Executive VP Of Cargo For Alaska Air Group

CORRECTION: Bernstein analyst Daniel Roeska downgrades General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) from Outperform to Market Perform and announces $53 price target (Analyst Name Updated - Originally Published on 23rd Sept 2024).

Downgrades

CORRECTION: Bernstein Downgrades General Motors to Market Perform, Announces $53 Price Target (Analyst Name Updated - Originally Published on 23rd Sept 2024)

KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) will release earnings results for its third quarter, after the <a href="https://www.benzinga.com/quote/KBH/earnings">closing bell on Tuesday</a>.
Analysts expect the Los Angeles-based company to report quarterly earnings at $2.06 per share. That&#8217;s up from $1.80 per share in the year-ago period. KB Home projects quarterly revenue of $1.73 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Sept. 19, Bank of America Securities analyst Rafe Jadrosich maintained KB Home with a Neutral rating and raised the price target from $75 to $90.
With the recent buzz around KB Home, some investors may be eyeing potential gains from the company's dividends. As of now, KB Home has a dividend yield of 1.15%. That&#8217;s a quarterly dividend amount of 25 cents a share ($1.00 a year).
To figure out how to earn $500 monthly from KB Home, we start with the yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by KB Home's $1.00 dividend: $6,000 / $1.00 = 6,000 shares
So, an investor would need to own approximately $523,380 worth of KB Home, or 6,000 shares to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $1.00 = 1,200 shares, or $104,676 to generate a monthly dividend income of $100.
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.
KBH Price Action: Shares of KB Home fell 2.6% to close at $87.23 on Friday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40962695/jim-cramer-viking-has-many-ships-coming-in">Jim Cramer: Viking Has &#8216;Many Ships Coming In&#8217;</a></li>
</ul>
Image: Shutterstock

Earnings

How To Earn $500 A Month From KB Home Stock Ahead Of Q3 Earnings

Macro Economic Events

Economics

Federal Reserve

Fed's Kashkari Says Penciled In 50 Basis Points More Cuts In 2024

AirBaltic Signs Long-Term EngineWise Maintenance Agreement With Pratt & Whitney For GTF Engine Fleet, Linking Costs To Engine Utilization

LTRN

Lantern Pharma Receives Three FDA Rare Pediatric Disease Designations For LP-184 In Malignant Rhabdoid Tumors, Rhabdomyosarcoma, And Hepatoblastoma, Bringing Total To Four RPDDs

WIIM

SPRC

SciSparc shares are trading higher after the company received FDA approval to initiate a Phase IIb clinical trial of SCI-110 for the treatment of Tourette syndrome.

Gorilla Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>)&nbsp;("Gorilla" or the "Company") and CS Energy Technology Co., Ltd., one of Asia's leading energy infrastructure providers, have announced a strategic cooperation agreement. This collaboration marks a transformative step in developing innovative solutions for smart and green cities across Thailand and Southeast Asia to shape a sustainable future.

Global

GRRR

Gorilla Technology And CS Energy Form AI-Powered Strategic Partnership To Accelerate The Rise Of Smart & Green Cities Across Thailand And Southeast Asia

SciSparc Receives FDA Approval To Initiate Phase IIb Clinical Trial Of SCI-110 In Tourette Syndrome Treatment

U.S. stocks settled higher on Friday, with the Dow Jones index settling at a record high during the session. The US Federal Reserve, on Wednesday, slashed interest rates by 50 basis points Wednesday at its September Federal Open Market Committee meeting, lowering the federal funds rate to a range of 4.75% to 5%.
All three major indices recorded weekly gains, with the S&amp;P 500 gaining around 1.4% and adding more than 19% in 2024. The Dow gained around 1.6% last week, while the tech-heavy Nasdaq jumped around 1.5% during the week.
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst&#8217;s opinion to trust.
Benzinga&#8217;s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market.
Top Analyst Picks: Fortunately, any Benzinga reader can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. One of the ways traders can sort through Benzinga&#8217;s extensive database of analyst ratings is by analyst accuracy. Here&#8217;s a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock</a> Ratings.
Analyst: Zachary Fadem
<ul>
<li>Analyst Firm: Wells Fargo</li>
<li>Ratings Accuracy: 87%</li>
<li>Latest Rating: Maintained an Equal-Weight rating on Darden Restaurants, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) and raised the price target from $160 to $165 on Sept. 20. This analyst sees around 3% downside in the stock.</li>
<li>Recent News: On Sept. 19, Darden Restaurants reported weaker-than-expected first-quarter financial results.</li>
</ul>
Analyst: Sam Reid
<ul>
<li>Analyst Firm: Wells Fargo</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Maintained an Overweight rating on Ferguson Enterprises Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FERG#NYSE">FERG</a>) and cut the price target from $250 to $225 on Sept. 18. This analyst sees around 13% upside in the stock.</li>
<li>Recent News: On Sept. 17, the company reported net sales of $7.946 billion, which was 1.4% higher year over year, missing the consensus of $7.993 billion.</li>
</ul>
Analyst: Mark Hughes
<ul>
<li>Analyst Firm: Truist Securities</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Maintained a Hold rating on Arthur J. Gallagher &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) and raised the price target from $265 to $275 on Sept. 20. This analyst sees around 0.4% downside in the stock.</li>
<li>Recent News: On July 25, Arthur J. Gallagher reported better-than-expected second-quarter revenue results.</li>
</ul>
Analyst: Josh Sullivan
<ul>
<li>Analyst Firm: Benchmark</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Reiterated a Buy rating on Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) with a price target of $10 on Sept. 18. This analyst sees more than 9% gain in the stock.</li>
<li>Recent News: On Sept. 17, Intuitive Machines announced it was awarded a NASA Near Space Network contract for communication and navigation services, with a maximum potential value of $4.82 billion.</li>
</ul>
Analyst: Aaron Raker
<ul>
<li>Analyst Firm: Wells Fargo</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Maintained an Overweight rating on Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) and cut the price target from $190 to $175 on Sept. 18. This analyst sees around 92% upside in the stock.</li>
<li>Recent News: On Sept. 17, Micron announced the availability of the Crucial P310 2280 Gen4 NVMe solid-state drive (SSD) which expands Micron's P310 portfolio to address PCs, laptops and PlayStation 5. The company said a version with a heatsink will be released in the coming months, suited for use with PlayStation 5 and desktop gaming PCs.</li>
</ul>
Read More:<a href="https://www.benzinga.com/markets/24/09/40962695/jim-cramer-viking-has-many-ships-coming-in"> </a>
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40962695/jim-cramer-viking-has-many-ships-coming-in">Jim Cramer: Viking Has &#8216;Many Ships Coming In&#8217;</a></li>
</ul>

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

iShares Exponential Technologies ETF

Overview

iShares Exponential Technologies ETF (NASDAQ:XT), Quote.Headers.trade-ideas